These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30969093)

  • 1. Serum miR-3142 could be Used as a Potential Biomarker to Screen Cervical Cancer Patients from Healthy Controls.
    Luo Q; Wang H; Li J
    Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
    Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
    Wang SY; Li Y; Jiang YS; Li RZ
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer.
    Zhao S; Yao D; Chen J; Ding N
    Genet Test Mol Biomarkers; 2013 Aug; 17(8):631-6. PubMed ID: 23819812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
    Yang L; Xu Q; Xie H; Gu G; Jiang J
    Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on serum miR-182 as a marker for diagnosis and prognosis of cervical cancer.
    Gao F; Wang Y; Li H; Yin J
    Technol Health Care; 2024; 32(5):3083-3095. PubMed ID: 38848201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the diagnostic and prognostic value of serum miR-770 in non-small cell lung cancer.
    Sun B; Liu HF; Ding Y; Li Z
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3061-3066. PubMed ID: 29863251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma.
    Chen J; Yao D; Li Y; Chen H; He C; Ding N; Lu Y; Ou T; Zhao S; Li L; Long F
    Int J Mol Med; 2013 Sep; 32(3):557-67. PubMed ID: 23799609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients.
    Zhang J; Wang T; Zhang Y; Wang H; Wu Y; Liu K; Pei C
    Cancer Biomark; 2018; 21(4):763-768. PubMed ID: 29286916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer.
    Zuberi M; Khan I; Gandhi G; Ray PC; Saxena A
    Tumour Biol; 2016 Aug; 37(8):11259-66. PubMed ID: 26951510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
    Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
    Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
    Li M; Li BY; Xia H; Jiang LL
    Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular identification of miR-145 and miR-9 expression level as prognostic biomarkers for early-stage cervical cancer detection.
    Azizmohammadi S; Safari A; Azizmohammadi S; Kaghazian M; Sadrkhanlo M; Yahaghi E; Farshgar R; Seifoleslami M
    QJM; 2017 Jan; 110(1):11-15. PubMed ID: 27345415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Value of Serum hsa-mir-92a in Patients with Cervical Cancer.
    Kong Q; Tang Z; Xiang F; Jiang J; Yue H; Wu R; Kang X
    Clin Lab; 2017 Feb; 63(2):335-340. PubMed ID: 28182350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
    Lv ZC; Fan YS; Chen HB; Zhao DW
    Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating and tissue miR-100 acts as a potential diagnostic biomarker for cervical cancer.
    Yamanaka Z; Sasaki T; Yamanaka A; Kato K; Nishi H
    Cancer Biomark; 2021; 32(4):551-558. PubMed ID: 34334379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma miR-127 and miR-218 Might Serve as Potential Biomarkers for Cervical Cancer.
    You W; Wang Y; Zheng J
    Reprod Sci; 2015 Aug; 22(8):1037-41. PubMed ID: 25701838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Value of Serum miR-106a in the Diagnosis and Prognosis of Human Papillomavirus-Positive Cervical Cancer.
    Rao X; Jiang J; Wang Y; Ma X; Liu S
    Intervirology; 2023; 66(1):54-62. PubMed ID: 36646059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.
    Hua Y; Chen H; Wang L; Wang F; Wang P; Ning Z; Li Y; Liu L; Chen Z; Meng Z
    Cancer Biomark; 2017 Jul; 20(1):95-100. PubMed ID: 28759959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
    Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.